Latest Insights Into Cardiovascular Risk in HIV-Infected Patients

Faculty:

Jens D. Lundgren, MD, DMSc Signe Westring Worm, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

• Describe how the epidemiology of cardiovascular risk is different in the HIV-infected population when compared with the general population
• Discuss the contribution of traditional risk factors to cardiovascular risk in HIV-infected patients
• Explain how untreated HIV contributes to cardiovascular risk in HIV-infected patients
• Relate how antiretroviral therapy contributes to cardiovascular risk in HIV-infected patients
• List several actions physicians may take to monitor and to mitigate cardiovascular risk in HIV-infected patients

Topics covered include:

• Introduction
• Basics of Evolution of Cardiovascular Disease
• Epidemiology of Cardiovascular Disease: General Population
• Epidemiology of Cardiovascular Disease: HIV-Infected Population
• Role of Traditional Risk Factors in the HIV-Infected Population
• Role of Traditional Risk Factors in the HIV-Infected Population: Dyslipidemia
• Role of Traditional Risk Factors in the HIV-Infected Population: Metabolic Syndrome
• HIV-Specific Risk Factors for Cardiovascular Disease
• Predicting Absolute Cardiovascular Disease Risk in Individual HIV-Infected Patients
• Summary: Implications for Clinical Practice